Literature DB >> 10914123

Trends in end-stage renal disease. Epidemiology, morbidity, and mortality.

S T Reikes1.   

Abstract

ESRD is always fatal unless recognized and treated appropriately. In the United States, the incidence of ESRD is increasing. Fortunately, both mortality among dialysis patients and the rate at which ESRD has been increasing over the past decade are declining. Obviously, the primary goal should be prevention of ESRD. Aggressive treatment of hypertension and hyperglycemia is likely to reduce the incidence of ESRD. Screening for diabetes and hypertension may be a fruitful approach to reduction in ESRD rates, because many patients present with renal failure after prolonged periods of undiagnosed hypertension or type 2 diabetes.

Entities:  

Mesh:

Year:  2000        PMID: 10914123     DOI: 10.3810/pgm.2000.07.1152

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  6 in total

1.  Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin.

Authors:  Fadia T Shaya; James Y Shin; Daniel Mullins; Hugh O Fatodu; Anna Gu; Elijah Saunders
Journal:  J Natl Med Assoc       Date:  2005-04       Impact factor: 1.798

2.  Uremic toxins are conditional danger- or homeostasis-associated molecular patterns.

Authors:  Yu Sun; Candice Johnson; Jun Zhou; Luqiao Wang; Ya-Feng Li; Yifan Lu; Gayani Nanayakkara; Hangfei Fu; Ying Shao; Claudette Sanchez; William Y Yang; Xin Wang; Eric T Choi; Rongshan Li; Hong Wang; Xiao-Feng Yang
Journal:  Front Biosci (Landmark Ed)       Date:  2018-01-01

3.  Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon.

Authors:  Marie P Halle; Christian Takongue; Andre P Kengne; François F Kaze; Kathleen B Ngu
Journal:  BMC Nephrol       Date:  2015-04-21       Impact factor: 2.388

4.  Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD.

Authors:  Sara T Ibrahim; Rajkumar Chinnadurai; Ibrahim Ali; Debbie Payne; Gillian I Rice; William G Newman; Eman Algohary; Ahmed G Adam; Philip A Kalra
Journal:  PLoS One       Date:  2020-01-31       Impact factor: 3.240

5.  Multicenter Investigation of the Initial Hemodialysis Vascular Access and Its Related Factors in Hangzhou of China.

Authors:  Qisu Ying; Yong Mao; Xiangcheng Xie; Ping Wu; Jilin Ma; Wei Zhou; Jinhua Xu; Xiao Fei; Ming Wang; Yingying Qian; Jiayu Shao; Xiaofeng Xia; Xiu Yang
Journal:  Biomed Res Int       Date:  2021-02-17       Impact factor: 3.411

6.  End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression.

Authors:  Ruijing Zhang; Jason Saredy; Ying Shao; Tian Yao; Lu Liu; Fatma Saaoud; William Y Yang; Yu Sun; Candice Johnson; Charles Drummer; Hangfei Fu; Yifan Lu; Keman Xu; Ming Liu; Jirong Wang; Elizabeth Cutler; Daohai Yu; Xiaohua Jiang; Yafeng Li; Rongshan Li; Lihua Wang; Eric T Choi; Hong Wang; Xiaofeng Yang
Journal:  Redox Biol       Date:  2020-02-20       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.